YN001

DRUG3 trials

Sponsors

Beijing Inno Medicine Co., Ltd.

Conditions

Atherosclerotic Cardiovascular DiseaseCardiovascular DiseasesHealthy Volunteers

Phase 1

A First-in-human Study of YN001 in Healthy Volunteers

CompletedNCT05635084

Beijing Inno Medicine Co., Ltd.Cardiovascular Diseases

Start: 2022-12-16End: 2024-08-09Updated: 2024-11-18

YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis

CompletedNCT06048588

Beijing Inno Medicine Co., Ltd.Atherosclerotic Cardiovascular Disease

Start: 2023-10-08End: 2025-04-27Updated: 2026-09-22

A Pharmacokinetic Study of YN001 in Healthy Participants

SuspendedNCT07190885

Beijing Inno Medicine Co., Ltd.Healthy Volunteers

Start: 2025-11-18End: 2026-09-01Target: 24Updated: 2026-09-23